Pars planitis - Clinical features and class II HLA associations

被引:109
作者
Raja, SC
Jabs, DA
Dunn, JP
Fekrat, S
Machan, CH
Marsh, MJ
Bressler, NM
机构
[1] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
关键词
D O I
10.1016/S0161-6420(99)90122-7
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To describe a cohort of patients with pars planitis followed at a single tertiary care institution, determine the frequency of multiple sclerosis and/or optic neuritis in patients with this disorder, and calculate gene frequencies of human leukocyte antigen (HLA) class II alleles in these patients. Design: Fifty-three patients with the diagnosis of pars planitis underwent clinical record review or telephone interview for follow-up or both; 32 of these underwent phlebotomy for analysis of HLA class II alleles, Main Outcome Measures: Outcomes included visual acuity, occurrence of multiple sclerosis and/or optic neuritis, and HLA class II gene frequencies. Results: With a mean follow-up of 2 years, approximately 90% of patients maintained a visual acuity better than 20/40 in at least one eye. The most frequently encountered ophthalmic complications included cystoid macular edema, cataract, and epiretinal membrane formation. Of 37 patients with pars planitis who had medical or neurologic follow-up evaluations, 6 (16.2%) developed multiple sclerosis, The HLA-DR15 allele, coding for one of the two HLA-DR2 subtypes, was associated with pars planitis (odds ratio = 2.86, 95% confidence interval = 1.42-5.78, P = 0.004), Conclusions: A common immunogenetic predisposition to multiple sclerosis and pars planitis may be associated with the HLA-DR15 allele, This association may represent genetic linkage to the HLA-DR locus or a role for the HLA-DR15 gene product in the pathogenesis of both of these diseases.
引用
收藏
页码:594 / 599
页数:6
相关论文
共 25 条
[11]   MULTIPLE-SCLEROSIS AND THE HLA-D REGION - LINKAGE AND ASSOCIATION STUDIES [J].
KELLARWOOD, HF ;
WOOD, NW ;
HOLMANS, P ;
CLAYTON, D ;
ROBERTSON, N ;
COMPSTON, DAS .
JOURNAL OF NEUROIMMUNOLOGY, 1995, 58 (02) :183-190
[12]  
MALINOWSKI SM, 1993, OPHTHALMOLOGY, V100, P818
[13]  
MALINOWSKI SM, 1993, OPHTHALMOLOGY, V100, P1199
[14]   ASSOCIATION OF HLA-DRW2 ANTIGEN WITH PRESUMED OCULAR HISTOPLASMOSIS [J].
MEREDITH, TA ;
SMITH, RE ;
DUQUESNOY, RJ .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1980, 89 (01) :70-76
[15]   HLA-DR TYPING BY PCR AMPLIFICATION WITH SEQUENCE-SPECIFIC PRIMERS (PCR-SSP) IN 2 HOURS - AN ALTERNATIVE TO SEROLOGICAL DR TYPING IN CLINICAL-PRACTICE INCLUDING DONOR-RECIPIENT MATCHING IN CADAVERIC TRANSPLANTATION [J].
OLERUP, O ;
ZETTERQUIST, H .
TISSUE ANTIGENS, 1992, 39 (05) :225-235
[16]   UVEITIS IN ASSOCIATION WITH MULTIPLE-SCLEROSIS [J].
PORTER, R .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1972, 56 (06) :478-&
[17]  
SCHEPENS CL, 1951, ACT 16 CONC OPHTH BR, V2, P1384
[18]  
SMITH RE, 1973, T AM ACAD OPHTHALMOL, V77, P760
[19]  
SMITH RE, 1983, HDB OPHTHALMOLOGY, P147
[20]   The association of HLA-DR15 and intermediate uveitis [J].
Tang, WM ;
Pulido, JS ;
Eckels, DD ;
Han, DP ;
Mieler, WF ;
Pierce, K .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 123 (01) :70-75